Initiator Pharma A/S Sustainability Reports

Initiator Pharma A/S is a clinical-stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous systems, with a focus on erectile dysfunction and female sexual dysfunction.

Sector: Manufacturing

Country: Denmark

Exchange: Nasdaq Stockholm

LEI: 213800DFI4I1A5RVKB59

FIGI: BBG00DX7CXF7

7 reports from 2017 to 2025

• Initiator Pharma A/S 2025 Annual Report
• Initiator Pharma A/S 2024 Annual Report
• Initiator Pharma A/S 2023 Annual Report
• Initiator Pharma A/S 2022 Annual Report
• Initiator Pharma A/S 2021 Annual Report